Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Memory Bridge is a U.S.-based nonprofit organization focused on improving quality of life for people living with dementia through education, relationship-building, and community-based programming. Founded in 2004 after beginning its work in 2003, the organization develops programs that connect students and other community members with older adults affected by Alzheimer's disease and related dementias. Its best-known work includes the Memory Bridge Initiative, which pairs young people with elders in structured one-to-one relationships designed to reduce emotional isolation and foster meaningful communication. The organization operates more like a mission-driven healthcare and elder-care nonprofit than a biotech or pharmaceutical company, and it does not appear to develop therapeutic drug assets or a traditional clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Memory Bridge.